Danaher Western Europe — Sales increased by 21.1% to $1.69B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.3%, from $1.49B to $1.69B. Over 4 years (FY 2021 to FY 2025), Western Europe — Sales shows a downward trend with a -3.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration or growing demand for the company's offerings in the region, while a decrease may signal competitive pressure, economic headwinds, or reduced regional spending.
This metric represents the total revenue generated from products and services sold within the Western European geographi...
Peers in the life sciences and diagnostics sector typically report regional revenue to demonstrate geographic diversification and exposure to specific healthcare markets.
dhr_segment_western_europe_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.77B | $1.67B | $1.86B | $1.83B | $1.69B | $1.54B | $1.85B | $1.71B | $1.71B | $1.47B | $585.00M | $1.32B | $1.32B | $1.32B | $1.49B | $1.34B | $1.51B | $1.40B | $1.69B |
| QoQ Change | — | -5.7% | +11.6% | -1.8% | -7.5% | -8.9% | +20.1% | -7.7% | +0.0% | -14.1% | -60.1% | +126.3% | -0.2% | -0.1% | +13.0% | -9.9% | +12.1% | -7.4% | +21.1% |
| YoY Change | — | — | — | — | -4.5% | -7.7% | -0.6% | -6.6% | +1.0% | -4.8% | -68.4% | -22.5% | -22.7% | -10.0% | +155.0% | +1.5% | +14.1% | +5.8% | +13.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.